TCTR20240513002已完成4 期
Comparison of Hepatitis B surface Antibody levels after vaccination with combined one dose hexavalent-based vaccine (DTaP-IPV-HB-Hib) with two doses of pentavalent-based vaccine (DTwP-HB-Hib) versus three doses of pentavalent-based vaccine (DTwP-HB-Hib)
Research center, Faculty of Medicine Ramathibodi Hospital, Mahidol University0 个研究点目标入组 76 人开始时间: 2024年5月13日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 Days 至 120 Days（—）
- 性别
- All
入选标准
- •Infants who born at a gestational age more than 36 weeks
- •Infants aged 30 to120 days who received a monovalent HBV vaccine at birth
排除标准
- •Infants not born to HIV- or HBV-infected mothers and those with coagulopathy
研究者
相似试验
已完成
不适用
Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis BCertain infectious and parasitic diseasesKCT0000087Ajou University101
已完成
3 期
Effect of Tetanus-diphtheria vaccine in promotion of immune response against hepatitis B vaccineChronic viral hepatitisHepatitis B.IRCT2014051015999N2Vice Chancellor for Research Isfahan University of Medical Sciences280
尚未招募
Unknown
Anti-HBs Antibody Titres among healthcare workers vaccinated against Hepatitis B in AIIMS RajkotCTRI/2024/07/070546All India Institute Of Medical Sciences Rajkot
已完成
不适用
Immune response to hepatitis B vaccine among HIV positive patientsCondition 1: chronic hepatitis B. Condition 2: Human Immunodeficeincy Virus.Chronic viral hepatitis B without delta-agent Chronic (viral) hepatitis BHIV disease resulting in haematological and immunological abnormalities, not elsewhere classifiedIRCT2015072023251N1Vice Chancellor of Hamadan University of Medical Sciences30
已完成
2 期
Comparing the Efficacy and Safety of Hepatitis B vaccine of Pasteur Institute of Iran and Cuban Heber biotec Company’s in Iranian healthy volunteersCondition 1: Acute Hepatitis B. Condition 2: Chronic (viral) hepatitis B.Acute hepatitis BChronic (viral) hepatitis BIRCT201109113307N5Pasteur Institute of Iran (IPI)440